Biotech news for Friday, July 10, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Immunome ( IMNM ) announced on Wednesday that the U.S. FDA has accepted its marketing application for its lead asset, varegacestat, targeted at a group of noncancerous soft tissue lesions known as desmoid tumors. The new drug application, targeting adults with…
Andy/iStock via Getty Images Prime Medicine ( PRME ) added ~8% in the premarket on Wednesday after an arbitration tribunal sided with the gene editing company in connection with a previously disclosed dispute with its rival Beam Therapeutics ( BEAM ). The disp…
BiomX ( PHGE ) said on Wednesday that it has signed a non-binding letter of intent to acquire a 60% controlling interest in Tsoock Defense Technologies for $10.4M. Tsoock serves as an execution and systems-integration contractor for leading Israeli system inte…
Chemomab Therapeutics ( CMMB ) and Scipher Medicine have entered into a definitive merger agreement pursuant to which the companies will combine in a stock transaction, the companies said on Wednesday. Upon completion of the merger, the combined company expect…
Defence Therapeutics ( DTCFF ) opened a new office at McMaster Innovation Park in Hamilton, Ontario, to support the expansion of its Accum radiopharmaceutical platform and business development activities. The biotechnology company said the new location will st…
Bone Biologics Corporation ( BBLG ) announced it has entered into a definitive agreement with a single healthcare-focused institutional investor for an at-the-market private placement expected to yield $3.0M in initial gross proceeds. The private placement inv…
ARS Pharmaceuticals ( SPRY ) appointed Donn Casale as chief executive officer and director, effective July 7, 2026, succeeding co-founder Richard Lowenthal. Richard Lowenthal stepped down as an employee and officer of the company, effective July 6, 2026. Casal…